---
figid: PMC5524075__JAH3-6-e005108-g007
figtitle: Interleukin (IL)‐13RA1 in myocardial metabolism
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5524075
filename: JAH3-6-e005108-g007.jpg
figlink: /pmc/articles/PMC5524075/figure/jah32162-fig-0007/
number: F7
caption: 'Interleukin (IL)‐13Rα1 in myocardial metabolism. A, Schematic description
  of the input used to simulate cardiac Il13ra1 −/− metabolism using GSMM. High‐throughput
  data from cardiac tissue of wild‐type (n=4) and Il13ra1 −/− (n=3) mice, and a GSMM
  were used as inputs. The iMAT algorithm integrates the gene‐expression data with
  a genome scale model in order to find a feasible solution space for metabolic flux
  distribution, thus enabling description of posttranscriptional modifications not
  shown by gene expression alone. B, Pathway enrichment analysis over the set of common
  reactions upregulated or downregulated in Il13ra1 −/− cardiac metabolism, computed
  via hypergeometric test and corrected for multiple hypotheses using a false discovery
  rate <0.05. C, Guided by changes in gene‐expression iMAT presents an aberrant energy
  metabolism in Il13ra1‐deficient hearts, consisting of a decrease in glycolysis and
  tricarboxylic acid cycle, with the upregulation of pyruvate. GSMM, genome scale
  metabolic modeling; iMAT, integrative metabolic analysis tool; TCA cycle, tricarboxylic
  acid cycle. Glycolytic metabolites: GLC, glucose; G6P, glucose 6‐phosphate; F6P,
  fructose 6‐phosphate; FDP, fructose 1,6‐bisphosphate; DHAP, dihydroxyacetone phosphate;
  G3P, glyceraldehyde 3‐phosphate; 1,3BPG, 1,3 bisphosphoglycerate; 3PG, 3‐phosphoglycerate;
  2PG, 2‐phosphoglycerate; PEP, phosphoenolpyruvate; PYR, pyruvate. TCA cycle metabolites:
  CIT, citrate; ICIT, isocitrate; AKG, α‐ketoglutarate; SUCCOA, succinyl‐CoA; SUC,
  succinate, FUM, fumarate; MAL, malate; OAA, oxaloacetate. Advance glycosylation
  end products: MTHGXL, methylglyoxal; LACG, lactoylglutathione; LALD, lactaldehyde.'
papertitle: New Role for Interleukin‐13 Receptor α1 in Myocardial Homeostasis and
  Heart Failure.
reftext: Uri Amit, et al. J Am Heart Assoc. 2017 May;6(5):e005108.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7508764
figid_alias: PMC5524075__F7
figtype: Figure
redirect_from: /figures/PMC5524075__F7
ndex: 212195ff-de8f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5524075__JAH3-6-e005108-g007.html
  '@type': Dataset
  description: 'Interleukin (IL)‐13Rα1 in myocardial metabolism. A, Schematic description
    of the input used to simulate cardiac Il13ra1 −/− metabolism using GSMM. High‐throughput
    data from cardiac tissue of wild‐type (n=4) and Il13ra1 −/− (n=3) mice, and a
    GSMM were used as inputs. The iMAT algorithm integrates the gene‐expression data
    with a genome scale model in order to find a feasible solution space for metabolic
    flux distribution, thus enabling description of posttranscriptional modifications
    not shown by gene expression alone. B, Pathway enrichment analysis over the set
    of common reactions upregulated or downregulated in Il13ra1 −/− cardiac metabolism,
    computed via hypergeometric test and corrected for multiple hypotheses using a
    false discovery rate <0.05. C, Guided by changes in gene‐expression iMAT presents
    an aberrant energy metabolism in Il13ra1‐deficient hearts, consisting of a decrease
    in glycolysis and tricarboxylic acid cycle, with the upregulation of pyruvate.
    GSMM, genome scale metabolic modeling; iMAT, integrative metabolic analysis tool;
    TCA cycle, tricarboxylic acid cycle. Glycolytic metabolites: GLC, glucose; G6P,
    glucose 6‐phosphate; F6P, fructose 6‐phosphate; FDP, fructose 1,6‐bisphosphate;
    DHAP, dihydroxyacetone phosphate; G3P, glyceraldehyde 3‐phosphate; 1,3BPG, 1,3
    bisphosphoglycerate; 3PG, 3‐phosphoglycerate; 2PG, 2‐phosphoglycerate; PEP, phosphoenolpyruvate;
    PYR, pyruvate. TCA cycle metabolites: CIT, citrate; ICIT, isocitrate; AKG, α‐ketoglutarate;
    SUCCOA, succinyl‐CoA; SUC, succinate, FUM, fumarate; MAL, malate; OAA, oxaloacetate.
    Advance glycosylation end products: MTHGXL, methylglyoxal; LACG, lactoylglutathione;
    LALD, lactaldehyde.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GluClalpha
  - betaGlu
  - pyr
  - ko
  - G6P
  - E(spl)malpha-BFM
  - fop
  - CycE
  - cyc
  - Fum1
  - mal
  - bs
  - Mrtf
  - Suc
  - Aldh-III
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - Pc
  - cs
  - Aco
  - Acox57D-d
  - Pgi
  - Pfk
  - CG15812
  - Ald1
  - Pgk
  - Tpi
  - Idh
  - Idh3b
  - Pgm1
  - Eno
  - pk
  - LKRSDH
  - SdhB
  - SdhA
  - Sodh-2
  - SdhC
  - fh
  - Mdh1
  - Mdh2
  - Men-b
  - Men
  - ACVR1
  - CEP43
  - CHTOP
  - OTOR
  - MAL
  - MRTFA
  - TIRAP
  - DECR1
  - APC
  - PROC
  - PC
  - CS
  - KLK15
  - BGN
  - GPI
  - PGPEP1
  - PFKL
  - PFKM
  - PFKP
  - FBXO3
  - TPI1
  - TWIST1
  - IDH1
  - IDH2
  - OGDH
  - VCAN
  - ENO1
  - ENO2
  - ENO3
  - ENO4
  - SARDH
  - SDHB
  - SORD
  - SDS
  - FH
  - MDH2
  - Pyruvate
---
